- Home
- PDM vs STAA Comparison
PDM vs STAA Comparison
Compare PDM & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDM | STAA |
|---|---|---|
| Founded | 1997 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Ophthalmic Goods |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 867.9M |
| IPO Year | 1997 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PDM | STAA |
|---|---|---|
| Price | $7.62 | $18.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 10 |
| Target Price | $9.00 | ★ $23.36 |
| AVG Volume (30 Days) | 864.3K | ★ 1.2M |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $564,994,000.00 | $313,901,000.00 |
| Revenue This Year | $0.91 | N/A |
| Revenue Next Year | $3.24 | $22.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.46 | $14.69 |
| 52 Week High | $9.19 | $30.81 |
Technical Indicators
Market Signals| Indicator | PDM | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 34.15 | 47.87 |
| Support Level | $7.17 | $16.02 |
| Resistance Level | $7.83 | $19.52 |
| Average True Range (ATR) | 0.37 | 0.75 |
| MACD | -0.10 | 0.34 |
| Stochastic Oscillator | 1.41 | 98.47 |
Price Performance
Historical ComparisonAbout PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.